FDA Approved: LAMOTRIGINE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for lamotrigine by Advagen Pharma Limited (ANDA 078625).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)